The Target-Based Discovery and Validation channel covers the latest scientific and technological advances enabling the discovery of small molecules targeting GPCRs, kinases, epigenetic proteins and protein degradation.

• Targeting the Ubiquitin-Proteasome System
• CNS and Neurodegenerative Targets
• Constrained Peptides and Macrocyclics
• Target Identification and Validation – Part 1

• Kinase Inhibitor Discovery
• GPCR-Based Drug Discovery
• Lead Generation Strategies
• Target Identification and Validation – Part 2